Filter News
Area of Research
- (-) Fusion Energy (2)
- (-) National Security (12)
- (-) Neutron Science (10)
- Advanced Manufacturing (1)
- Biology and Environment (21)
- Clean Energy (26)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (9)
- Isotope Development and Production (1)
- Isotopes (7)
- Materials (18)
- Materials for Computing (3)
- Nuclear Science and Technology (4)
- Quantum information Science (1)
- Supercomputing (23)
News Topics
- (-) Biomedical (5)
- (-) Cybersecurity (9)
- (-) Environment (4)
- (-) Exascale Computing (1)
- (-) Fusion (4)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (2)
- Artificial Intelligence (7)
- Big Data (1)
- Bioenergy (4)
- Biology (5)
- Biotechnology (1)
- Chemical Sciences (2)
- Climate Change (1)
- Composites (1)
- Computer Science (13)
- Coronavirus (5)
- Decarbonization (1)
- Energy Storage (3)
- Frontier (2)
- Grid (1)
- High-Performance Computing (2)
- Machine Learning (4)
- Materials (7)
- Materials Science (13)
- Microscopy (1)
- Nanotechnology (6)
- National Security (11)
- Neutron Science (40)
- Nuclear Energy (3)
- Partnerships (4)
- Physics (8)
- Quantum Science (4)
- Security (6)
- Summit (4)
- Sustainable Energy (2)
- Transportation (3)
Media Contacts
Oak Ridge National Laboratory will give college students the chance to practice cybersecurity skills in a real-world setting as a host of the Department of Energy’s fifth collegiate CyberForce Competition on Nov. 16. The event brings together student teams from across the country to compete at 10 of DOE’s national laboratories.
The U.S. Department of Energy announced funding for 12 projects with private industry to enable collaboration with DOE national laboratories on overcoming challenges in fusion energy development.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.